+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Next Generation Contact Lenses and Visual Prostheses Market Distribution by Type of Contact Lenses, Targeted Indication, Modality, Design, Material, Distribution Channel, and Geographical Region - Trends and Forecast Till 2035

  • PDF Icon

    Report

  • 324 Pages
  • September 2026
  • Region: Global
  • Roots Analysis
  • ID: 6284235

NEXT GENERATION CONTACT LENSES AND VISUAL PROSTHESES MARKET: OVERVIEW

The global next generation contact lenses and visual prostheses market is estimated to grow from USD 0.60 billion in the current year to USD 16.97 billion by 2035, reflecting a compound annual growth rate (CAGR) of approximately 39.7% during the forecast period.

Next Generation Contact Lenses and Visual Prostheses Market: Growth and Trends

The rising incidence of refractive disorders, including myopia, hyperopia, presbyopia and astigmatism, has fueled steady demand for corrective lenses. Conventional eyeglasses, while effective, offer a restricted field of vision, fog under humid conditions and exert pressure on the nose bridge and temples. These factors prompt a gradual shift toward thin, comfortable contact lenses that are less affected by environmental conditions.

Beyond vision correction, expanding unmet needs in ophthalmology and the availability of advanced biomaterials have widened the scope of contact lens applications. The American Academy of Ophthalmology has reported nearly 2 million eye injuries annually in the United States that result in vision loss, a trend that has accelerated the development of therapeutic lenses designed to treat and protect the eye. To date, ten contact lens-based products have secured FDA approval for indications beyond vision correction, including CUSTOMFLEX ARTIFICIALIRIS for aniridia (approved 2018) and EYEMATE for glaucoma monitoring (approved 2017).

Additionally, the growing population of blind and partially sighted individuals is a parallel driver of innovation. The National Eye Institute estimates nearly 1.3 million people are blind and 2.9 million have poor vision in the US alone, with these figures projected to rise to 2.2 million and 5 million, respectively, by 2030. This trend has intensified interest in next generation vision restoration technologies, particularly visual prostheses (bionic eyes), which use electrical stimulation of the optic nerve to restore functional vision. Sustained investment and technological progress across both contact lens and visual prosthesis platforms are expected to support significant market expansion as more solutions clear clinical evaluation and reach commercialization.

Growth Drivers: Factors Fueling Market Expansion

Market growth is primarily due to the rising global burden of refractive errors and ocular disorders, compounded by an ageing population increasingly prone to presbyopia, age-related macular degeneration, dry eye and cataracts. Older patients often struggle with the manual dexterity required for eye drop administration, a limitation that favors drug-eluting lenses capable of sustained, targeted therapeutic delivery. Growing awareness of the comfort and advantages of contact lenses over conventional eyewear, along with increasing R&D on diagnostic lenses for diabetes and glaucoma, continues to drive demand across corrective, therapeutic, and monitoring applications.

Market Challenges: Critical Barriers Hindering Progress

The high cost associated with specialized lens categories, including multifocal, toric and hybrid designs, remains a meaningful barrier to broader adoption, particularly in price-sensitive healthcare markets. The continued availability of alternative vision-correction options, such as LASIK surgery and conventional eyeglasses, adds further competitive pressure. Improper handling during lens insertion and removal carries an inherent risk of ocular infection, a concern that developers must continue to address through patient education and product design. Finally, the intensity of competition among established and emerging players places sustained pressure on developers to differentiate through innovation.

Growth Trends: Technology and Application Expansion

Advances in silicone hydrogel materials that improve corneal oxygen transmission, along with blue light-filtering technologies, continue to enhance the performance and applications of next generation contact lenses. Rising demand for disposable cosmetic lenses, increasing consumer focus on eye health, and growing development activity around antimicrobial coatings and moisture-retention technologies are reinforcing category growth. The emergence of bionic eye platforms has further concentrated industry attention on vision-restoration applications, positioning visual prostheses as a distinct and fast-evolving growth avenue within the broader market.

Next Generation Contact Lenses and Visual Prostheses Market: Key Insights

The report delves into the current state of the next generation contact lenses and visual prostheses market and identifies potential growth opportunities within the industry, particularly from a distributor and channel-partner perspective. Some key findings include:
  • Silicone hydrogel is the leading lens material, valued for its oxygen permeability and comfort, gas permeable lenses are expected to grow at a faster rate owing to the clarity of vision they offer.
  • Retail stores presently account for the largest distribution share, supported by competitive pricing and the availability of promotional discounts, while online stores are expected to grow at the highest CAGR, driven by the convenience of digital purchasing.
  • Over 7,000 patents related to next generation contact lenses and visual prostheses have been filed / granted to date, reflecting the sustained pace of innovation in the field.
  • Recent developments, including Google's AI-enabled smart eyewear platform, XPANCEO's AI-powered smart contact lens for glaucoma management, and FDA clearance of the Deseyne presbyopia lens, point to accelerating convergence between contact lens innovation and digital health / augmented reality ecosystems.
  • While traditional refractive correction still holds the largest foundational baseline, diagnostics/monitoring lenses and therapeutic drug-eluting contact lenses represent the fastest-growing application sub-segments. For channel partners, these high-value, clinically integrated products carry significantly higher average selling prices (ASPs) and offer opportunities to pivot from traditional retail margin models to recurring medical-supply contracts.
  • While North America and Europe retain dominant revenue shares due to early regulatory clearances and clinical trial infrastructure, the Asia-Pacific region is expanding at the highest CAGR. This trajectory is propelled by alarming rates of pediatric and young-adult myopia in urban East Asia (80-90% prevalence), coupled with expanding advanced medical electronics supply chains, marking APAC as a critical expansion market for regional distribution agreements.

Next Generation Contact Lenses and Visual Prostheses Market Segments

Roots Analysis segments the global Next Generation Contact Lenses and Visual Prostheses opportunity across the following parameters:

By Type of Contact Lenses

  • Corrective Lenses
  • Therapeutic Lenses
  • Drug-Eluting Lenses
  • Diagnostics / Monitoring Lenses
  • Visual Prosthesis

By Targeted Indication

  • Diabetes
  • Glaucoma
  • Age-Related Macular Degeneration
  • Retinitis Pigmentosa
  • Aniridia

By Modality

  • Reusable
  • Disposable

By Design

  • Toric
  • Multifocal
  • Spherical

By Material

  • Silicone Hydrogel
  • Gas Permeable (Orthokeratology and Scleral)
  • Others

By Distribution Channel

  • Ophthalmologists
  • Retail Stores
  • Online Stores

By Geographical Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Next Generation Contact Lenses and Visual Prostheses Market: Key Segments Insight

Market Share by Type of Contact Lens

According to our estimates, diagnostic / monitoring lenses are expected to account for the largest share of the market. This dominance is primarily driven by rapid advancements in smart contact lens technologies capable of continuously monitoring physiological and ocular biomarkers, including intraocular pressure, tear glucose, inflammatory biomarkers, and hydration status. Increasing investments in wearable biosensors, miniaturized electronics, wireless data transmission, and AI-enabled remote patient monitoring have accelerated the development of diagnostic lenses for chronic disease management. Furthermore, growing demand for non-invasive healthcare solutions and personalized medicine is expected to reinforce adoption across ophthalmology and digital health applications.

Meanwhile, drug-eluting lenses are expected to register the highest CAGR during the forecast period. Their strong growth is supported by the ability to provide sustained and localized drug delivery, improving therapeutic efficacy while reducing dosing frequency and improving patient compliance compared to conventional eye drops. Expanding clinical research involving glaucoma, dry eye disease, postoperative care, ocular infections, and retinal disorders, coupled with increasing regulatory and industry interest in sustained ocular drug delivery platforms, is expected to accelerate commercialization over the coming decade.

Market Share by Target Indication

According to our market analysis, diabetes is expected to capture the largest market share. This highest share is attributed to the continuously expanding global diabetic population and the growing prevalence of diabetic retinopathy. Significant research efforts focused on smart contact lenses capable of continuously monitoring tear glucose levels have further strengthened commercial interest in diabetes-focused ocular diagnostics. Additionally, increasing emphasis on remote patient monitoring and preventive disease management is expected to support sustained market expansion.

Conversely, glaucoma is projected to witness the fastest CAGR during the forecast period. This growth is driven by the rising incidence of glaucoma worldwide, increasing demand for continuous intraocular pressure monitoring, and ongoing development of contact lenses integrating pressure-sensing technologies and sustained ocular drug delivery systems. Since glaucoma often progresses asymptomatically, continuous monitoring solutions capable of enabling early intervention are expected to witness increasing clinical adoption.

Market Share by Modality Type

According to our analysis, disposable lenses currently account for the largest share of the market and are expected to maintain their leadership throughout the forecast period. Their widespread adoption is supported by superior hygiene, reduced maintenance requirements, improved patient convenience, and a lower risk of microbial contamination and lens-related infections compared to reusable alternatives. Growing preference for daily disposable lenses, especially among first-time and younger users, along with advances in lens materials that improve comfort and oxygen permeability, is expected to further drive segment growth.

It is important to note here that this segment is likely to register higher CAGR during the forecast period as manufacturers increasingly introduce premium single-use smart lenses incorporating sensing, therapeutic, and drug-delivery capabilities.

Market Share by Type of Design

According to our projections, spherical lenses currently account for the largest share of the market. Their leadership is attributed to the high global prevalence of refractive errors such as myopia and hyperopia, making spherical lenses the most commonly prescribed contact lens design. Further, their relatively simple manufacturing process, broad product availability, and high wearer comfort have further strengthened their commercial adoption.

However, toric lenses are expected to register the highest CAGR during the forecast period. Rising awareness and diagnosis of astigmatism, together with continuous improvements in stabilization technologies that enhance lens orientation and visual performance, are driving increasing adoption. Furthermore, manufacturers continue to expand premium toric product portfolios using advanced silicone hydrogel materials and customized fitting technologies, contributing to sustained segment growth.

Market Share by Type of Material

According to the proprietary market report, silicone hydrogel accounts for the largest market share. This dominance is primarily attributed to its superior oxygen permeability, enhanced comfort, better moisture retention, and lower risk of eye dryness and oxygen-related complications compared to conventional hydrogel materials. Continuous product innovation aimed at extending wearing time while maintaining ocular health has further accelerated adoption across both corrective and specialty contact lens applications.

On the other hand, gas permeable lenses are expected to witness the fastest CAGR during the forecast period. Increasing utilization in orthokeratology for myopia management, growing adoption of scleral lenses for irregular corneal disorders, and superior optical performance for complex vision correction are expected to drive segment expansion. Rising clinical acceptance of specialty lenses for keratoconus and post-surgical corneal conditions further supports long-term market growth.

Market Share by Distribution Channel

According to our estimates, retail stores currently generate the highest market share of the market. This highest share is due to their extensive product availability, established customer trust, professional fitting services, and immediate product accessibility. Strong partnerships between major manufacturers and optical retail chains continue to strengthen this distribution channel globally.

However, online stores are expected to register the fastest CAGR during the forecast period. Increasing healthcare digitalization, growing preference for e-commerce platforms, competitive pricing, subscription-based lens services, and convenient home delivery have significantly increased online contact lens purchases. The expanding adoption of tele-optometry and digital prescription verification is also expected to support long-term growth of online distribution channels.

Market Share by Geographical Region

According to our projections, Europe is expected to account for the largest market share. The region benefits from advanced ophthalmology infrastructure, high adoption of innovative contact lens technologies, strong research activities, and the presence of leading ophthalmic device manufacturers. Increasing prevalence of age-related ocular disorders, expanding utilization of specialty and disposable lenses, and growing investment in smart wearable ophthalmic technologies continue to support regional market leadership.

In contrast, Asia-Pacific is anticipated to witness the highest CAGR throughout the forecast period. This growth is driven by rapidly expanding healthcare expenditure, rising disposable incomes, increasing prevalence of myopia and diabetes, improving access to ophthalmic care, and growing awareness regarding preventive eye health. Moreover, expanding manufacturing capabilities, increasing R&D investments, and supportive government initiatives promoting digital healthcare and advanced medical technologies are expected to drive Asia-Pacific's rapid market growth through 2035.

Example Players in Next Generation Contact Lenses and Visual Prostheses Market

  • ALCON
  • Bausch + Lomb
  • CooperCompanies
  • Contamac
  • EssilorLuxottica
  • Euclid Vision Group
  • HOYA CORPORATION
  • Johnson & Johnson
  • Menicon
  • Novartis AG
  • SEED
  • Surgical Vision
  • STAAR SURGICAL
  • X-Cel Specialty Contacts

Industry Experts Insights

The opinions and insights presented in this study were shaped by discussions held with multiple stakeholders active in the next generation contact lenses and visual prostheses market. The report features detailed transcripts of interviews conducted with the following industry representatives:
  • Michal Shavit, Head of Sales and Marketing, EyeYon Medical
  • Mark E. Byrne, Co-Founder and Chief Technical Officer, OcuMedic
  • Praful Doshi, Founder, Chief Executive Officer and Chief Technical Officer, Leo Lens Technology

NEXT GENERATION CONTACT LENSES AND VISUAL PROSTHESES MARKET: RESEARCH COVERAGE

  • Market Sizing and Forecast: Detailed revenue projections for the overall market and its sub-segments by type of product / lenses, targeted indication and geography across North America, EU5 and Asia-Pacific, till 2030, under conservative, base and optimistic scenarios.
  • Market Overview: A comprehensive assessment of the next generation contact lens and visual prosthesis landscape, covering type of developer, location of developer headquarters, status of development, target indication, type of product and (for visual prostheses) implant site, along with the geographical distribution of stakeholder players and key opinion leaders.
  • Promotional Analysis: An analysis of the channels used for promotional campaigns by industry players, including product websites, brochure and user manual analysis, featuring dedicated assessments of marketed products such as ChromaGen, CUSTOMFLEX ARTIFICIALIRIS, EYEMATE, Hyper-CL, Implantable Miniature Telescope and SENSIMED Triggerfish.
  • Technology Profiles: Profiles of novel technologies being developed to expand contact lens functionality, namely EyePrintPRO, Interscatter Communication Technology, Leo Lens Technology, Nanowafer Technology and Diamond Eye Technology, including developer overview and working mechanism.
  • Patent Analysis: An analysis of patents filed / granted related to next generation contact lenses and visual prostheses since 2021, based on publication year, geography, CPC classification, emerging focus areas, leading industry and non-industry players, benchmarking and patent valuation.
  • Partnerships and Collaborations: A review of partnerships established in this domain, covering type of partnership, type of organization, application area, target indication and regional (intercontinental / intracontinental) distribution.
  • Emerging Trends on Social Media: An analysis of prevalent and emerging discussion trends related to next generation contact lenses and visual prostheses on Twitter, including trending words / phrases and the most prolific authors.
  • KOL Analysis: Identification and benchmarking of principal investigators, sub-investigators and study directors involved in relevant clinical trials, along with detailed profiles of prominent key opinion leaders and a Roots Analysis versus third-party scoring comparison.
  • Interview Transcripts: Detailed transcripts of interviews conducted with representatives of EyeYon Medical, OcuMedic and Leo Lens Technology.

Key Questions Answered in this Report

  • Which companies are currently active in the next generation contact lenses and visual prostheses market?
  • Which region dominates the next generation contact lenses and visual prostheses market?
  • What are the key trends observed in this market?
  • What factors are likely to influence the evolution of this market through 2035?
  • What are the primary challenges faced by developers of next generation contact lenses and visual prostheses?
  • What is the current and future size of this market?
  • What is the CAGR of this market during the forecast period?
  • How is the current and future market opportunity likely to be distributed across key market segments?

Reasons to Buy this Report

This report has been specifically developed to support distributors, channel partners, and business development teams evaluating entry into the next generation contact lenses and visual prostheses market.
  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments, valuable to both established market leaders and emerging entrants.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities and challenges, empowering data-driven decision-making.
  • The report can aid businesses in identifying future opportunities across the value chain and assessing whether those opportunities are worth pursuing.
  • The report helps identify customer demand by outlining the needs, preferences and behavior of the target audience, supporting effective product and service positioning.
  • The report equips new entrants with the requisite market information to build successful business strategies.
  • The report supports more effective communication with stakeholders and helps in building strong business relationships.

Additional Benefits

  • Complementary Insights Pack
  • Complementary PPT Insights Pack
  • Complementary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Context and Background
3.2. An Overview of Contact Lenses
3.2.1. Evolution of Contact Lenses
3.2.2. Applications of Contact Lenses
3.2.3. Types of Contact Lenses
3.2.4. Classification of Contact Lenses
3.2.4.1. Therapeutic Contact Lenses
3.2.4.2. Drug-Eluting Contact Lenses
3.2.4.2.1. Mechanism of Drug Delivery through Contact Lenses
3.2.4.2.2. Techniques for Developing Drug-Eluting Contact Lenses
3.2.4.3. Diagnostic / Monitoring Contact Lenses
3.3. Visual Prostheses
3.3.1. Architecture of a Bionic Eye
3.3.2. Working of a Bionic Eye
3.4. Key Therapeutic Indications
3.5. Prevalent Trends and Future Perspectives
4. MARKET OVERVIEW
4.1. Chapter Overview
4.2. Next Generation Contact Lenses: Overall Market Landscape
4.2.1. Distribution by Type of Developer
4.2.2. Distribution by Location of Headquarters of Developers
4.2.3. Distribution by Status of Development
4.2.4. Distribution by Target Indication
4.2.5. Distribution by Type of Product
4.3. Next Generation Contact Lenses: Market Landscape of Therapeutic Lenses
4.4. Next Generation Contact Lenses: Market Landscape of Drug-Eluting Lenses
4.5. Next Generation Contact Lenses: Market Landscape of Diagnostic / Monitoring Lenses
4.6. Visual Prostheses: Overall Market Landscape
4.6.1. Distribution by Type of Developer
4.6.2. Distribution by Location of Headquarters of Developers
4.6.3. Distribution by Status of Development
4.6.4. Distribution by Target Indication
4.6.5. Distribution by Implant Site
4.7. Geographical Distribution of Stakeholder Players and KOLs
5. PROMOTIONAL ANALYSIS
5.1. Chapter Overview
5.2. An Overview of Channels Used for Promotional Campaigns
5.3. Channels Adopted by Industry Players for Promotional Campaigns
5.3.1. Product Website Analysis
5.3.2. Product Brochure Analysis
5.3.3. Product User Manual Analysis
5.4. ChromaGen™: Promotional Analysis
5.4.1. Product Overview
5.4.2. Product Website / Brochure Analysis
5.4.2.1. Messages for Healthcare Professionals
5.4.2.2. Messages for Patients
5.5. CUSTOMFLEX® ARTIFICIALIRIS: Promotional Analysis
5.5.1. Product Overview
5.5.2. Product Website / Brochure Analysis
5.5.2.1. Messages for Healthcare Professionals
5.5.2.2. Messages for Patients
5.5.2.3. Other Messages
5.5.3. Other Promotional Activities
5.5.3.1. Publication in Journals
5.6. EYEMATE®: Promotional Analysis
5.6.1. Product Overview
5.6.2. Product Website / Brochure Analysis
5.6.2.1. Messages for Healthcare Professionals
5.6.2.2. Messages for Patients
5.6.3. Other Promotional Activities
5.6.3.1. Publication in Journals
5.7. Hyper-CL™: Promotional Analysis
5.7.1. Product Overview
5.7.2. Product Website / Brochure Analysis
5.7.2.1. Messages for Healthcare Professionals
5.7.2.2. Messages for Patients
5.7.3. Product User Manual Analysis
5.7.3.1. Other Messages
5.7.4. Other Promotional Activities
5.7.4.1. Publication in Journals
5.8. Implantable Miniature Telescope: Promotional Analysis
5.8.1. Product Overview
5.8.2. Product Website / Brochure Analysis
5.8.2.1. Messages for Healthcare Professionals
5.8.2.2. Patient Access Program
5.8.2.3. Other Messages
5.8.3. Product User Manual Analysis
5.8.3.1. Messages for Patients
5.8.4. Other Promotional Activities
5.8.4.1. Publication in Journals
5.9. SENSIMED Triggerfish®: Promotional Analysis
5.9.1. Product Overview
5.9.2. Product Website / Brochure Analysis
5.9.2.1. Messages for Healthcare Professionals
5.9.2.2. Messages for Patients
5.9.3. Product User Manual Analysis
5.9.3.1. Other Messages
5.9.4. Other Promotional Activities
5.9.4.1. Publication in Journals
5.9.4.2. Presence in Conferences
6. TECHNOLOGY PROFILES
6.1. Chapter Overview
6.2. Next Generation Contact Lenses: Novel Technologies
6.3. EyePrintPRO™
6.3.1. Developer Overview
6.3.2. Technology Overview
6.3.2.1. Working Mechanism
6.4. Interscatter Communication Technology
6.4.1. Developer Overview
6.4.2. Technology Overview
6.4.2.1. Working Mechanism
6.5. Leo Lens Technology
6.5.1. Developer Overview
6.5.2. Technology Overview
6.5.2.1. Working Mechanism
6.6. Nanowafer Technology
6.6.1. Developer Overview
6.6.2. Technology Overview
6.6.2.1. Working Mechanism
6.7. The Diamond Eye™ Technology
6.7.1. Developer Overview
6.7.2. Technology Overview
6.7.2.1. Working Mechanism
7. PATENT ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Next Generation Contact Lenses and Visual Prostheses: Patent Analysis
7.3.1. Analysis by Publication Year
7.3.2. Analysis by Geographical Location
7.3.3. Analysis by CPC Classification
7.3.4. Emerging Focus Areas
7.3.5. Leading Industry Players by Number of Patents
7.3.6. Leading Non-Industry Players by Number of Patents
7.4. Next Generation Contact Lenses and Visual Prostheses: Patent Benchmarking Analysis (Industry Players)
7.4.1. Analysis by CPC Classification
7.4.2. Analysis by Geography
7.5. Next Generation Contact Lenses and Visual Prostheses: Patent Benchmarking Analysis (Non-Industry Players)
7.5.1. Analysis by CPC Classification
7.5.2. Analysis by Geography
7.6. Next Generation Contact Lenses and Visual Prostheses: Patent Valuation Analysis
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Next Generation Contact Lenses and Visual Prostheses: List of Partnerships and Collaborations
8.3.1. Analysis by Type of Partnership
8.3.2. Analysis by Type of Organization
8.3.3. Analysis by Area of Application
8.3.4. Analysis by Target Indication
8.3.5. Regional Analysis
8.3.5.1. Intercontinental and Intracontinental Agreements
9. EMERGING TRENDS ON SOCIAL MEDIA
9.1. Chapter Overview
9.2. Next Generation Contact Lenses and Visual Prostheses: Trends on Twitter
9.2.1. Social Media Analysis: Trending Words / Phrases Related to Next Generation Contact Lenses and Visual Prostheses on Twitter
9.2.2. Social Media Analysis: Most Prolific Authors on Twitter
10. KOL ANALYSIS
10.1. Chapter Overview
10.2. Methodology
10.3. Principal Investigators / Sub-Investigators / Study Directors Involved in Clinical     Trials
10.3.1. Geographical Distribution
10.4. Prominent Key Opinion Leaders
10.5. KOL Benchmarking: Roots Analysis versus Third Party Scoring
10.6. Prominent Key Opinion Leaders
10.6.1. Profile: KOL A (Wills Eye Hospital)
10.6.2. Profile: KOL B (Retina Foundation of the Southwest)
10.6.3. Profile: KOL C (Rabin Medical Center)
10.6.4. Profile: KOL D (University of Oxford)
10.6.5. Profile: KOL E (New York Eye and Ear Infirmary)
10.6.6. Profile: KOL F (Fred Hutchinson Cancer Research Center)
11. MARKET SIZING AND FORECAST
11.1. Chapter Overview
11.2. Forecast Methodology
11.3. Overall Next Generation Contact Lenses and Visual Prostheses Market, Till 2035
11.3.1. Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Product, Till 2035
11.3.1.1. Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Lenses, Till 2035
11.3.2. Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Target Indications, Till 2035
11.3.3. Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Regions, Till 2035
11.4. Next Generation Contact Lenses and Visual Prostheses Market in North America, Till 2035
11.4.1. Next Generation Contact Lenses and Visual Prostheses Market in North America: Distribution by Type of Product, Till 2035
11.4.1.1. Next Generation Contact Lenses and Visual Prostheses Market in North America: Contact Lenses, Till 2035
11.4.1.1.1. Next Generation Contact Lenses and Visual Prostheses Market in North America: Therapeutic Lenses, Till 2035
11.4.1.1.2. Next Generation Contact Lenses and Visual Prostheses Market in North America: Drug-Eluting Lenses, Till 2035
11.4.1.1.3. Next Generation Contact Lenses and Visual Prostheses Market in North America: Diagnostic / Monitoring Lenses, Till 2035
11.4.1.2. Next Generation Contact Lenses and Visual Prostheses Market in North America: Visual Prostheses, Till 2035
11.4.2. Next Generation Contact Lenses and Visual Prostheses Market in North America: Distribution by Target Indication, Till 2035
11.4.2.1. Next Generation Contact Lenses and Visual Prostheses Market in North America: Diabetes, Till 2035
11.4.2.2. Next Generation Contact Lenses and Visual Prostheses Market in North America: Glaucoma, Till 2035
11.4.2.3. Next Generation Contact Lenses and Visual Prostheses Market in North America: Age-related Macular Degeneration, Till 2035
11.4.2.4. Next Generation Contact Lenses and Visual Prostheses Market in North America: Retinitis Pigmentosa, Till 2035
11.4.2.5. Next Generation Contact Lenses and Visual Prostheses Market in North America: Aniridia, Till 2035
11.5. Next Generation Contact Lenses and Visual Prostheses Market in EU5, Till 2035
11.5.1. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Distribution by Type of Product, Till 2035
11.5.1.1. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Contact Lenses, Till 2035
11.5.1.1.1. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Therapeutic Lenses, Till 2035
11.5.1.1.2. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Drug-Eluting Lenses, Till 2035
11.5.1.1.3. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diagnostic / Monitoring Lenses, Till 2035
11.5.1.2. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Visual Prostheses, Till 2035
11.5.2. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Distribution by Target Indication, Till 2035
11.5.2.1. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diabetes, Till 2035
11.5.2.2. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Glaucoma, Till 2035
11.5.2.3. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Age-related Macular Degeneration, Till 2035
11.5.2.4. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Retinitis Pigmentosa, Till 2035
11.5.2.5. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Aniridia, Till 2035
11.6. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific, Till 2035
11.6.1. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Distribution by Type of Product, Till 2035
11.6.1.1. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Contact Lenses, Till 2035
11.6.1.1.1. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Therapeutic Lenses, Till 2035
11.6.1.1.2. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Drug-Eluting Lenses, Till 2035
11.6.1.1.3. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diagnostic / Monitoring Lenses, Till 2035
11.6.1.2. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Visual Prostheses, Till 2035
11.6.2. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Distribution by Target Indication, Till 2035
11.6.2.1. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diabetes, Till 2035
11.6.2.2. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Glaucoma, Till 2035
11.6.2.3. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Age-related Macular Degeneration, Till 2035
11.6.2.4. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Retinitis Pigmentosa, Till 2035
12. INTERVIEW TRANSCRIPTS
12.1. Chapter Overview
12.2. EyeYon Medical
12.2.1. Interview Transcript: Michal Shavit, Head of Sales and Marketing
12.3. OcuMedic
12.3.1. Interview Transcript: Mark E. Byrne, Co-Founder and Chief Technical Officer
12.4. Leo Lens Technology
12.4.1. Interview Transcript: Praful Doshi, Founder, Chief Executive Officer and Chief Technical Officer
13. CONCLUSION
13.1. Advances in Ophthalmic Lens Technologies have Enabled the Development of Contact Lenses for Therapeutic, Bandage and Diagnostic Use
13.2. The Competitive Landscape Features a Mix of Industry and Academic Players; Majority of Stakeholder are based in the US
13.3. Rising Interest in this Domain is Evident from Increasing Social Media Chatter and the Partnership Activity
13.4. Technology Developers are Spearheading the Innovation, and Making Substantial     Contributions to the Intellectual Capital in this Field
13.5. Driven by Anticipated Growth in Target Population, coupled to the Ongoing Innovation, the Market is Likely to Witness Steady Growth over the Next Decade
14. APPENDIX 1: TABULATED DATA15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
List of Tables
Table 3.1 Advantages and Disadvantages of Different Types of Contact Lenses
Table 4.1 List of Next Generation Contact Lenses
Table 4.2 List of Therapeutic Contact Lenses
Table 4.3 List of Drug-Eluting Contact Lenses
Table 4.4 List of Diagnostic / Monitoring Contact Lenses
Table 4.5 List of Visual Prostheses
Table 5.1 ChromaGen™: Product Overview
Table 5.2 CUSTOMFLEX® ARTIFICIALIRIS: Product Overview
Table 5.3 EYEMATE®: Product Overview
Table 5.4 Hyper-CL™: Product Overview
Table 5.5 Implantable Miniature Telescope: Product Overview
Table 5.6 SENSIMED Triggerfish®: Product Overview
Table 5.7 Other Promotional Activities: Presence in Conferences
Table 6.1 List of Novel Technologies in Next Generation Contact Lens and Visual Prosthesis Market
Table 6.2 EyePrintPRO™: Technology Overview
Table 6.3 Interscatter Communication: Developer Overview
Table 6.4 Interscatter Communication: Technology Overview
Table 6.5 Leo Lens Technology: Developer Overview
Table 6.6 Leo Lens Technology: Technology Overview
Table 6.7 Nanowafer Technology: Developer Overview
Table 6.8 Nanowafer Technology: Technology Overview
Table 6.9 The Diamond Eye™ Technology: Developer Overview
Table 6.10 The Diamond Eye™ Technology: Technology Overview
Table 7.1 Patent Analysis: Most Popular CPC Symbols
Table 7.2 Patent Analysis: List of Top CPC Classifications
Table 7.3 Patent Analysis: Top Five CPC Classification Symbols (Johnson & Johnson Vision)
Table 7.4 Patent Analysis: Top Five CPC Classification Symbols (Novartis)
Table 7.5 Patent Analysis: Top Five CPC Classification Symbols (Allergan)
Table 7.6 Patent Analysis: Top Five CPC Classification Symbols (Transitions Optical)
Table 7.7 Patent Analysis: Top Five CPC Classification Symbols (Google)
Table 7.8 Patent Analysis: Top Five CPC Classification Symbols (Massachusetts General Hospital)
Table 7.9 Patent Analysis: Top Five CPC Classification Symbols (University of California)
Table 7.10 Patent Analysis: Top Five CPC Classification Symbols (Massachusetts Institute of Technology)
Table 7.11 Patent Analysis: Top Five CPC Classification Symbols (University of Colorado)
Table 7.12 Patent Analysis: Top Five CPC Classification Symbols (University of Illinois Ophthalmology)
Table 7.13 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 7.14 Patent Analysis: List of Leading Patents
Table 8.1 Next Generation Contact Lenses and Visual Prostheses: Partnerships and Collaborations
Table 10.1 KOL Analysis: List of Principal Investigators / Sub-Investigators / Study Directors
Table 10.2 KOL Analysis: List of Universities and Hospitals
Table 10.3 KOL Analysis: Scoring System
Table 10.4 Profile: KOL A (Wills Eye Hospital)
Table 10.5 Profile: KOL B (Retina Foundation of the Southwest)
Table 10.6 Profile: KOL C (Rabin Medical Center)
Table 10.7 Profile: KOL D (University of Oxford)
Table 10.8 Profile: KOL E (New York Eye and Ear Infirmary)
Table 10.9 Profile: KOL F (Fred Hutchinson Cancer Research Center)
Table 11.1 Assumptions: Likely Prices of Different Types of Products
Table 11.2 Assumptions: Likely Adoption Rates of Different Types of Products
Table 14.1 Next Generation Contact Lenses: Distribution by Type of Developer
Table 14.2 Next Generation Contact Lenses: Distribution by Type of Developer and Type of Contact Lenses
Table 14.3 Next Generation Contact Lenses: Distribution by Location of Headquarters of Developer
Table 14.4 Next Generation Contact Lenses: Distribution by Location of Headquarters of Developers and Type of Contact Lenses
Table 14.5 Next Generation Contact Lenses: Distribution by Status of Development
Table 14.6 Next Generation Contact Lenses: Distribution by Status of Development and Type of Contact Lenses
Table 14.7 Next Generation Contact Lenses: Distribution by Target Indication
Table 14.8 Next Generation Contact Lenses: Distribution by Target Indication and Type of Contact Lenses
Table 14.9 Next Generation Contact Lenses: Distribution by Type of Product
Table 14.10 Visual Prostheses: Distribution by Type of Developer
Table 14.11 Visual Prostheses: Distribution by Location of Headquarters of Developer
Table 14.12 Visual Prostheses: Distribution by Status of Development
Table 14.13 Visual Prostheses: Distribution by Target Indication
Table 14.14 Visual Prostheses: Distribution by Implant Site
Table 14.15 Patent Analysis: Distribution by Type of Patent
Table 14.16 Patent Analysis: Cumulative Distribution by Publication Year, 2013-2018
Table 14.17 Patent Analysis: Distribution by Geography
Table 14.18 Patent Analysis: Leading Industry Players
Table 14.19 Patent Analysis: Leading Non-Industry Players
Table 14.20 Patent Analysis (Industry Players): Number of Patents Across Different Geographies
Table 14.21 Patent Analysis (Industry Players): Benchmarking by International Patents
Table 14.22 Patent Analysis (Non-Industry Players): Number of Patents Across Different Geographies
Table 14.23 Patent Analysis (Non-Industry Players): Benchmarking by International Patents
Table 14.24 Patent Analysis: Distribution of Patents by Age (January 2013- Mid October 2018)
Table 14.25 Partnerships and Collaborations: Distribution by Type of Partnership
Table 14.26 Partnerships and Collaborations: Distribution by Type of Organization
Table 14.27 Partnerships and Collaborations: Distribution by Application Areas
Table 14.28 Partnerships and Collaborations: Distribution by Target Indication
Table 14.29 Partnerships and Collaborations: Regional Distribution
Table 14.30 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Table 14.31 Overall Next Generation Contact Lenses and Visual Prostheses Market, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.32 Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Product, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.33 Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Contact Lenses, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.34 Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Target Indications, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.35 Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Regions, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.36 Next Generation Contact Lenses and Visual Prostheses Market in North America, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.37 Next Generation Contact Lenses and Visual Prostheses Market in North America: Contact Lenses, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.38 Next Generation Contact Lenses and Visual Prostheses Market in North America: Therapeutic Lenses, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.39 Next Generation Contact Lenses and Visual Prostheses Market in North America: Drug-Eluting Lenses, Conservative, Base and Optimistic Scenario, 2022-2030 (USD Million)
Table 14.40 Next Generation Contact Lenses and Visual Prostheses Market in North America: Diagnostic / Monitoring Lenses, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.41 Next Generation Contact Lenses and Visual Prostheses Market in North America: Visual Prostheses, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.42 Next Generation Contact Lenses and Visual Prostheses Market in North America: Diabetes, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.43 Next Generation Contact Lenses and Visual Prostheses Market in North America: Glaucoma, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.44 Next Generation Contact Lenses and Visual Prostheses Market in North America: Age-related Macular Degeneration, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.45 Next Generation Contact Lenses and Visual Prostheses Market in North America: Retinitis Pigmentosa, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.46 Next Generation Contact Lenses and Visual Prostheses Market in North America: Aniridia, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.47 Next Generation Contact Lenses and Visual Prostheses Market in EU5, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.48 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Contact Lenses, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.49 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Therapeutic Lenses, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.50 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Drug-Eluting Lenses, Conservative, Base and Optimistic Scenario, 2023-2030 (USD Million)
Table 14.51 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diagnostic / Monitoring Lenses, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.52 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Visual Prostheses, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.53 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diabetes, Conservative, Base and Optimistic Scenario, 2026-2030 (USD Million)
Table 14.54 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Glaucoma, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.55 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Age-related Macular Degeneration, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.56 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Retinitis Pigmentosa, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.57 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Aniridia, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.58 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.59 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Contact Lenses, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.60 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Therapeutic Lenses, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.61 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Drug-Eluting Lenses, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.62 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diagnostic / Monitoring Contact Lenses, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.63 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Visual Prostheses, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.64 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diabetes, Conservative, Base and Optimistic Scenario, 2028-2030 (USD Million)
Table 14.65 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Glaucoma, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.66 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Age-related Macular Degeneration, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
Table 14.67 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Retinitis Pigmentosa, Conservative, Base and Optimistic Scenario, Till 2035 (USD Million)
List of Figures
Figure 3.1 Historical Evolution of Contact Lenses
Figure 3.2 Applications of Bandage Contact Lenses
Figure 3.3 Barriers to Ocular Drug Delivery
Figure 3.4 Novel Approaches for Corneal Drug Delivery
Figure 3.5 Steps Involved in Molecular Imprinting
Figure 3.6 Visual Prostheses: External and Implantable Modules
Figure 3.7 Visual Prostheses: Mode of Operation
Figure 3.8 Key Therapeutic Indications Targeting Contact Lenses and Visual Prostheses
Figure 4.1 Next Generation Contact Lenses: Distribution by Type of Developer
Figure 4.2 Next Generation Contact Lenses: Distribution by Type of Developer and Type of Contact Lenses
Figure 4.3 Next Generation Contact Lenses: Distribution by Location of Headquarters of Developer
Figure 4.4 Next Generation Contact Lenses: Distribution by Location of Headquarters of Developer and Type of Contact Lenses
Figure 4.5 Next Generation Contact Lenses: Distribution by Status of Development
Figure 4.6 Next Generation Contact Lenses: Distribution by Status of Development and Type of Contact Lenses
Figure 4.7 Next Generation Contact Lenses: Distribution by Target Indication
Figure 4.8 Next Generation Contact Lenses: Distribution by Target Indication and Type of Contact Lenses
Figure 4.9 Next Generation Contact Lenses: Distribution by Type of Product
Figure 4.10 Visual Prostheses: Distribution by Type of Developer
Figure 4.11 Visual Prostheses: Distribution by Location of Headquarters of Developer
Figure 4.12 Visual Prostheses: Distribution by Status of Development
Figure 4.13 Visual Prostheses: Distribution by Target Indication
Figure 4.14 Visual Prostheses: Distribution by Implant Site
Figure 4.15 Visual Prostheses: Logo Landscape of Bionic Eye Developers based on Implant Site
Figure 4.16 Next Generation Contact Lenses and Visual Prostheses: Geographical Distribution of Stakeholder Players and KOLs
Figure 5.1 Promotional Strategy: Channels Adopted for Promotional Campaigns
Figure 5.2 Promotional Strategy: Product Website Analysis
Figure 5.3 Promotional Strategy: Product Brochure Analysis
Figure 5.4 Promotional Strategy: Product User Manual Analysis
Figure 5.5 ChromaGen™ Product Website Analysis: Messages for Healthcare Professionals
Figure 5.6 ChromaGen™ Product Website Analysis: Messages for Patients
Figure 5.7 CUSTOMFLEX® ARTIFICIALIRIS Product Brochure Analysis: Warnings and Precautions
Figure 5.8 CUSTOMFLEX® ARTIFICIALIRIS Product Website Analysis: Messages for Patients
Figure 5.9 CUSTOMFLEX® ARTIFICIALIRIS Product Brochure Analysis: Other Messages
Figure 5.10 EYEMATE® Product Website Analysis: Messages for Healthcare Professionals
Figure 5.11 EYEMATE® Product Website Analysis: Key Advantages
Figure 5.12 Hyper-CL™ Product Brochure Analysis: Messages for Healthcare Professionals
Figure 5.13 Hyper-CL™ Product Brochure Analysis: Messages for Healthcare Professionals, Comparative Study Results
Figure 5.14 Hyper-CL™ Product Website Analysis: Messages for Patients
Figure 5.15 Hyper-CL™ Product User Manual Analysis: Warnings and Precautions
Figure 5.16 Hyper-CL™ Product User Manual Analysis: General Instructions and Lens Handling Information
Figure 5.17 Implantable Miniature Telescope Product Brochure Analysis: Messages for Healthcare Professionals
Figure 5.18 Implantable Miniature Telescope Product Brochure Analysis: Reimbursement Information
Figure 5.19 Implantable Miniature Telescope Product Brochure Analysis: Other Messages
Figure 5.20 Implantable Miniature Telescope Product User Manual Analysis: Messages for Patients
Figure 5.21 SENSIMED Triggerfish® Product Website Analysis: Key Advantages
Figure 5.22 SENSIMED Triggerfish® Product Website Analysis: Messages for Healthcare Professionals
Figure 5.23 SENSIMED Triggerfish® Product Brochure Analysis: Data Visualization and Interpretation Information
Figure 5.24 SENSIMED Triggerfish® Product Website Analysis: Messages for Patients
Figure 5.25 SENSIMED Triggerfish® Product User Manual Analysis: Warnings and Precautions
Figure 5.26 SENSIMED Triggerfish® Product User Manual Analysis: Other Messages
Figure 6.1 Leo Lens Technology: Components
Figure 7.1 Patent Analysis: Distribution by Type of Patent
Figure 7.2 Patent Analysis: Cumulative Distribution by Publication Year, 2013-2018
Figure 7.3 Patent Analysis: Distribution by Geography
Figure 7.4 Patent Analysis: Distribution by CPC Classification
Figure 7.5 Patent Analysis: Emerging Focus Areas
Figure 7.6 Patent Analysis: Leading Industry Players
Figure 7.7 Patent Analysis: Leading Non-Industry Players
Figure 7.8 Patent Analysis (Industry Players): Number of Patents across Different Geographies
Figure 7.9 Patent Analysis (Industry Players): Benchmarking by International Patents
Figure 7.10 Patent Analysis (Non-Industry Players): Number of Patents across Different Geographies
Figure 7.11 Patent Analysis (Non-Industry Players): Benchmarking by International Patents
Figure 7.12 Patent Analysis: Distribution of Patents by Age (January 2013- Mid October 2018)
Figure 7.13 Patent Analysis: Valuation Analysis
Figure 8.1 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Organization
Figure 8.3 Partnerships and Collaborations: Distribution by Application Areas
Figure 8.4 Partnerships and Collaborations: Distribution by Target Indication
Figure 8.5 Partnerships and Collaborations: Regional Distribution
Figure 8.6 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Figure 9.1 Social Media Analysis: Trending Words / Phrases on Twitter
Figure 9.2 Social Media Analysis: Trending Words / Phrases on Twitter Based on Focus Area
Figure 9.3 Social Media Analysis: Most Prolific Authors
Figure 9.4 Social Media Analysis: Bubble Chart Analysis Based on Average Likes, Re-tweets and Comments Related to Next Generation Contact Lenses and Visual Prostheses, on Twitter
Figure 10.1 KOL Analysis: Geographical Distribution of Principal Investigators / Sub-Investigators / Study Directors
Figure 10.2 KOL Analysis: Dot-Plot of Principal Investigators
Figure 10.3 KOL Benchmarking: Roots Analysis versus Third Party Scoring
Figure 10.4 KOL Benchmarking: Roots Analysis versus Third Party Scoring (Scatter Plot)
Figure 10.5 KOL Analysis: Most Prominent Key Opinion Leaders
Figure 11.1 Overall Next Generation Contact Lenses and Visual Prostheses Market, Till 2035 (USD Million)
Figure 11.2 Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Product, Till 2035 (USD Million)
Figure 11.3 Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Lenses, Till 2035 (USD Million)
Figure 11.4 Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Target Indications, Till 2035 (USD Million)
Figure 11.5 Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Regions, Till 2035 (USD Million)
Figure 11.6 Next Generation Contact Lenses and Visual Prostheses Market in North America, Till 2035 (USD Million)
Figure 11.7 Next Generation Contact Lenses and Visual Prostheses Market in North America: Contact Lenses, Till 2035 (USD Million)
Figure 11.8 Next Generation Contact Lenses and Visual Prostheses Market in North America: Therapeutic Lenses, Till 2035 (USD Million)
Figure 11.9 Next Generation Contact Lenses and Visual Prostheses Market in North America: Drug-Eluting Lenses, 2022-2030 (USD Million)
Figure 11.10 Next Generation Contact Lenses and Visual Prostheses Market in North America: Diagnostic / Monitoring Lenses, Till 2035 (USD Million)
Figure 11.11 Next Generation Contact Lenses and Visual Prostheses Market in North America: Visual Prostheses, Till 2035 (USD Million)
Figure 11.12 Next Generation Contact Lenses and Visual Prostheses Market in North America: Diabetes, Till 2035 (USD Million)
Figure 11.13 Next Generation Contact Lenses and Visual Prostheses Market in North America: Glaucoma, Till 2035 (USD Million)
Figure 11.14 Next Generation Contact Lenses and Visual Prostheses Market in North America: Age-related Macular Degeneration, Till 2035 (USD Million)
Figure 11.15 Next Generation Contact Lenses and Visual Prostheses Market in North America; Retinitis Pigmentosa, Till 2035 (USD Million)
Figure 11.16 Next Generation Contact Lenses and Visual Prostheses Market in North America: Aniridia, Till 2035 (USD Million)
Figure 11.17 Next Generation Contact Lenses and Visual Prostheses Market in EU5, Till 2035 (USD Million)
Figure 11.18 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Contact Lenses, Till 2035 (USD Million)
Figure 11.19 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Therapeutic Lenses, Till 2035 (USD Million)
Figure 11.20 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Drug-Eluting Lenses, 2023-2030 (USD Million)
Figure 11.21 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diagnostic / Monitoring Lenses, Till 2035 (USD Million)
Figure 11.22 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Visual Prostheses, Till 2035 (USD Million)
Figure 11.23 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diabetes, 2026-2030 (USD Million)
Figure 11.24 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Glaucoma, Till 2035 (USD Million)
Figure 11.25 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Age-related Macular Degeneration, Till 2035 (USD Million)
Figure 11.26 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Retinitis Pigmentosa, Till 2035 (USD Million)
Figure 11.27 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Aniridia, Till 2035 (USD Million)
Figure 11.28 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific, Till 2035 (USD Million)
Figure 11.29 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Contact Lenses, Till 2035 (USD Million)
Figure 11.30 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Therapeutic Lenses, Till 2035 (USD Million)
Figure 11.31 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Drug-Eluting Lenses, Till 2035 (USD Million)
Figure 11.32 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diagnostic / Monitoring Contact Lenses, Till 2035 (USD Million)
Figure 11.33 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Visual Prostheses, Till 2035 (USD Million)
Figure 11.34 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diabetes, 2028-2030 (USD Million)
Figure 11.35 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Glaucoma, Till 2035 (USD Million)
Figure 11.36 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Age-related Macular Degeneration, Till 2035 (USD Million)
Figure 11.37 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Retinitis Pigmentosa, Till 2035 (USD Million)
Figure 13.1 Next Generation Contact Lenses: Logo Landscape of Developers across Different Regions, Type of Contact Lenses and Type of Organization
Figure 13.2 Overall Next Generation Ophthalmic Contact Lenses and Visual Prostheses Market, Conservative, Base and Optimistic Scenarios, 2019, 2025 and 2030 (USD Million)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ALCON
  • Bausch + Lomb
  • CooperCompanies
  • Contamac
  • EssilorLuxottica
  • Euclid Vision Group
  • HOYA CORPORATION
  • Johnson & Johnson
  • Menicon
  • Novartis AG
  • SEED
  • Surgical Vision
  • STAAR SURGICAL
  • X-Cel Specialty Contacts

Methodology

 

 

Loading
LOADING...